☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
sanofi
Sanofi and Regeneron Reports the EC’s Approval of Dupixent (Dupilumab) for Young Children with Eosinophilic Esophagitis (EoE)
November 6, 2024
Sanofi Collaborates with Orano Med for the Development of Next-Generation Radioligand Therapies
October 17, 2024
Sanofi and Regeneron’s Dupixent Receives the US FDA’s and NMPA’s Approval to Treat Chronic Obstructive Pulmonary Disease (COPD)
September 30, 2024
Sanofi and Regeneron’s Dupixent Receives the CHMP’s Positive Opinion for Treating Eosinophilic Esophagitis (EoE) in Children
September 23, 2024
Sanofi Reports the P-III (HERCULES) Study Results of Tolebrutinib for Treating Non-Relapsing Secondary Progressive Multiple Sclero...
September 20, 2024
Sanofi and Regeneron’s Dupixent Receives the US FDA’s Approval to Treat Adolescents with Chronic Rhinosinusitis with Nasal Polyps...
September 16, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.